Author: Publisher:
ISBN:
Category : Drugs
Languages : en
Pages :
Book Description
Prescription Drugs
Author: Prescription drugs many factors affected FDA's approval of selected "pipeline" drugs : report to congressional requesters.
Author: Publisher: DIANE Publishing
ISBN: 1428972536
Category :
Languages : en
Pages : 58
Book Description
Prescription Drugs
Author: Janet HeinrichPublisher: DIANE Publishing
ISBN: 9780756708092
Category :
Languages : en
Pages : 60
Book Description
World Drug Report 2021 (Set of 5 Booklets)
Author: United Nations Office on Drugs and CrimePublisher: United Nations
ISBN: 9210058038
Category : Political Science
Languages : en
Pages : 508
Book Description
As in previous reports, the 2021 World Drug Report (WDR) aims to improve the understanding of the worlds drug problem and to contribute towards fostering greater international cooperation for countering its impact on health, governance and security. Also, to the extent possible, the WDR contributes to the monitoring and reporting of SDGs. This edition includes an updated overview of recent trends on production, trafficking and consumption for non-medical purposes of key controlled substances. It further maintains a global overview of the baseline data and estimates on drug demand and supply and provides an analysis of the market for the different drugs.
Impact of Prescription Drug Diversion Control Systems on Medical Practice and Patient Care
Author: Publisher:
ISBN:
Category : Drug traffic
Languages : en
Pages : 356
Book Description
Framework for Equitable Allocation of COVID-19 Vaccine
Author: National Academies of Sciences, Engineering, and MedicinePublisher: National Academies Press
ISBN: 030968224X
Category : Medical
Languages : en
Pages : 273
Book Description
In response to the coronavirus disease 2019 (COVID-19) pandemic and the societal disruption it has brought, national governments and the international community have invested billions of dollars and immense amounts of human resources to develop a safe and effective vaccine in an unprecedented time frame. Vaccination against this novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), offers the possibility of significantly reducing severe morbidity and mortality and transmission when deployed alongside other public health strategies and improved therapies. Health equity is intertwined with the impact of COVID-19 and there are certain populations that are at increased risk of severe illness or death from COVID-19. In the United States and worldwide, the pandemic is having a disproportionate impact on people who are already disadvantaged by virtue of their race and ethnicity, age, health status, residence, occupation, socioeconomic condition, or other contributing factors. Framework for Equitable Allocation of COVID-19 Vaccine offers an overarching framework for vaccine allocation to assist policy makers in the domestic and global health communities. Built on widely accepted foundational principles and recognizing the distinctive characteristics of COVID-19, this report's recommendations address the commitments needed to implement equitable allocation policies for COVID-19 vaccine.
Sharing Clinical Trial Data
Author: Institute of MedicinePublisher: National Academies Press
ISBN: 0309316324
Category : Medical
Languages : en
Pages : 304
Book Description
Data sharing can accelerate new discoveries by avoiding duplicative trials, stimulating new ideas for research, and enabling the maximal scientific knowledge and benefits to be gained from the efforts of clinical trial participants and investigators. At the same time, sharing clinical trial data presents risks, burdens, and challenges. These include the need to protect the privacy and honor the consent of clinical trial participants; safeguard the legitimate economic interests of sponsors; and guard against invalid secondary analyses, which could undermine trust in clinical trials or otherwise harm public health. Sharing Clinical Trial Data presents activities and strategies for the responsible sharing of clinical trial data. With the goal of increasing scientific knowledge to lead to better therapies for patients, this book identifies guiding principles and makes recommendations to maximize the benefits and minimize risks. This report offers guidance on the types of clinical trial data available at different points in the process, the points in the process at which each type of data should be shared, methods for sharing data, what groups should have access to data, and future knowledge and infrastructure needs. Responsible sharing of clinical trial data will allow other investigators to replicate published findings and carry out additional analyses, strengthen the evidence base for regulatory and clinical decisions, and increase the scientific knowledge gained from investments by the funders of clinical trials. The recommendations of Sharing Clinical Trial Data will be useful both now and well into the future as improved sharing of data leads to a stronger evidence base for treatment. This book will be of interest to stakeholders across the spectrum of research--from funders, to researchers, to journals, to physicians, and ultimately, to patients.
Pharmaceutical Innovation and Access to Medicines
Author: OECDPublisher: Org. for Economic Cooperation & Development
ISBN: 9789264307384
Category : Drug accessibility
Languages : en
Pages : 0
Book Description
This report reviews the important role of medicines in health sytems, describes recent trends in pharmaceutical expenditure and financing, and summarises the approaches used by OECD countries to determine coverage and pricing.
An Undisciplined Economist
Author: Morris L. BarerPublisher: McGill-Queen's Press - MQUP
ISBN: 0773599479
Category : Medical
Languages : en
Pages :
Book Description
For four decades Robert Evans has been Canada’s foremost health policy analyst and commentator, playing a leadership role in the development of both health economics and population health at home and internationally. An Undisciplined Economist collects Evans’ most important contributions and includes two new articles. The topics addressed range widely, from the peculiar structure of the health care industry to the social determinants of the health of entire populations to the misleading role that economists have sometimes played in health policy debates. Written with Evans' characteristic clarity, candour, and wit, these essays unabashedly expose health policy myths and the special interests that lie behind them. He refutes claims that public health insurance is unsustainable, that the health care costs of an aging population will bankrupt Canada, that user charges will make the health care system more efficient, and that health care is the most important determinant of a population’s health. An Undisciplined Economist is a valuable collection for those familiar with Evans’ work, a lucid introduction for those new to the fields of health economics, health policy, and population health, and a fitting tribute to an outstanding scholar.
Artificial Intelligence in Health
Author: Fernando KochPublisher: Springer
ISBN: 3030127389
Category : Computers
Languages : en
Pages : 245
Book Description
This book constitutes the refereed post-conference proceedings of the First International Workshop on Artificial Intelligence in Health, AIH 2018, in Stockholm, Sweden, in July 2018. This workshop consolidated the workshops CARE, KRH4C and AI4HC into a single event. The 18 revised full papers included in this volume were carefully selected from the 26 papers accepted for presentation out of 42 initial submissions. The papers present AI technologies with medical applications and are organized in three tracks: agents in healthcare; data science and decision systems in medicine; and knowledge management in healthcare.
